Here are stocks that are in news today:
Results Today: ITC, Sun Pharma, DLF, HPCL, 3M India, Divis Laboratories, Tech Mahindra, ONGC, SUN TV, Crompton Greaves Consumer Electricals, CG Power And Industrial Solutions, Indoco Remedies, NBCC (India), Tata Chemicals, Torrent Pharmaceuticals, Mahanagar Gas, Alkem Laboratories, Eros International Media, Indian Hotels, Maharashtra Seamless, OMDC, Sudarshan Chemical, Sunteck Realty, Trent, Gujarat Alkalies Chemicals, Gujarat State Financial Corporation, Arman Financial Services, Asahi Songwon Colors, Asian Hotels (West), Associated Alcohols Breweries, Allied Digital Services, Borax Morarji, Eros International Media, Excel Industries, FDC, Finolex Industries, Geojit Financial Services, Hind Rectifiers, IFB Industries, Jindal Drilling Industries, Kakatiya Cement Sugar Industries, Kamat Hotels, Kwality, Maharashtra Seamless, Mandhana Industries, Manugraph India, Satin Creditcare Network
Tata Power
Issuance of non-convertible debentures of Rs 500 crore
IDBI Bank
CARE revises rating to CARE A negative of Lower tier II bond amounting to 50cr
Crafts Comprehensive Turnaround strategy; takes steps to shore up capital
Infosys
Announces strategic alliance with HP Inc. to Accelerate Digital Transformation for the Enterprise
Glenmark Pharma
S&P Global Ratings has reaffirmed our credit rating as BB
NALCO
Inks MOU with Government of India setting Higher Targets in production
Fortune Financial
Board has approved raising of equity capital up to Rs. 400 crore, through private placement, QIP
IT stocks (Infosys, TCS, Tech Mahondra)
Cognizant says not planning layoffs
Dr Reddy’s
SEZ unit completes USFDA inspection for second time
IDBI Bank
Bank plans to raise more money as part of its turnaround plan
Cipla Q4
Cons Net Loss At Rs 61.8 Cr Vs CNBC-TV18 Poll Of Rs 346.8 Cr Profit
Cons Revenue At Rs 3,582 Cr Vs CNBC-TV18 Poll Of Rs 3,790 Cr
Cons EBITDA At Rs 506.2 Cr Vs CNBC-TV18 Poll Of Rs 675.4 Cr
Cons EBITDA Margin At 14.1 percent Vs CNBC-TV18 Poll Of 17.8 percent
Cons Net Loss At Rs 61.8 Cr Vs Loss Of Rs 93 Cr (YoY)
Cons Revenue (GU)8.1 percent At Rs 3,582 Cr Vs Rs 3,314 Cr (YoY)
Cons EBITDA At Rs 506.2 Cr Vs Rs 176.1 Cr (YoY)
Depreciation, Impairment At Rs 632 Cr Vs Rs 270 Cr (YoY)
Cipla Says
Co Took Impairments Of Rs 214 Cr In Jan-March On Us Generic Ops
Made Rs 56 Cr Provisions For Cipla’s Biotech Assets
Cipla Says
Worst Hit By Price Erosion By NPPA Decision,Yet India Growth Ahead Of Mkt
Operationally, This Quarter Is In Line With Our EBIDTA Range Of 16 percent
Co Took Impairments Of Rs 214 Cr In In Jan-March On US Generic Ops
Made Rs 56 Cr Provisions For Biotech Assets
Paid Rs 1,000 Cr Of Debt This Year
Will Be Very Active On Licensed Drugs & Organic Development Of Molecules
Filed 11 ANDAs In Q4, 32 In Full Year
Expect Volatility In Indian Market In Coming Months Due To GST
Expect To File For Approval Of Respiratory Pdts In US By Next Year
Co Has Taken 6 percent Markdown On US Biz, Do Not Anticipate Further Markdown
Cipla CEO Says See Significant Hit On India Sales From GST Rollout
Hotel Leela Q4
Net Profit At Rs 13.4 Cr Vs Loss Of Rs 229 Cr (YoY)
Revenue At Rs 198.3 cr Vs Rs 194 Cr (YoY)
Hotel Leela
Board Approves Allotment Of 16.4 Cr Eq Shares To JM Fin ARC Worth Rs 275 Cr
Adlabs Entertainment Q4
Cons Net Loss At Rs 31.6 Cr Vs Loss Of Rs 28.6 Cr (YoY)
Cons Revenue (GU)4.9 percent At Rs 55.7 Cr Vs Rs 53.1 Cr (YoY)
Britannia Q4
Cons Net Profit At Rs 211 Cr Vs CNBC-TV18 Poll Of Rs 208 Cr
Cons Revenue At Rs 2,316 Cr Vs CNBC-TV18 Poll Of Rs 2,392 Cr
Cons EBITDA At Rs 308.1 Cr Vs CNBC-TV18 Poll Of Rs 312 Cr
Cons EBITDA Margin At 13.3 percent Vs CNBC-TV18 Poll Of 13 percent
Cons Net Profit (GU)5.9 percent At Rs 211 Cr Vs Rs 199 Cr (YoY)
Cons Revenue (GU)5.8 percent At Rs 2,316 Cr Vs Rs 2,189 Cr (YoY)
Cons EBITDA (GU)6.1 percent At Rs 308.1 Cr Vs Rs 290.3 Cr (YoY)
Cons EBITDA Margin Unchanged At 13.3 percent
Britannia Announces Dividend Of Rs 22/Sh
Manappuram Finance Q4
Cons Net Profit At Rs 200 Cr Vs Rs 130 Cr (YoY)
Cons Total Income At Rs 890 Cr Vs Rs 650 Cr (YoY)
Heidelberg Cement Q4
Net Profit (GU)49.2 percent At Rs 37 Cr Vs Rs 24.8 Cr (YoY)
Revenue (GU)15.2 percent At Rs 538.6 Cr Vs Rs 467.7 Cr (YoY)
EBITDA (GU)15.2 percent At Rs 79.2 Cr Vs Rs 69.4 Cr (YoY)
EBITDA Margin At 17.11 percent Vs 17.25 percent Cr (YoY)
Subex Q4
Cons Net Loss Of Rs 93.7 Cr Vs Rs 41.3 Cr Loss (YoY)
Cons Total Income At Rs 94.9 Cr Vs Rs 89.3 Cr (YoY)
Thomas Cook Q4
Cons Net Loss At Rs 6.3 Cr Vs Loss Of Rs 87.5 Cr (YoY)
Cons Total Income At Rs 2059.2 Cr Vs Rs 1865.7 Cr (YoY)
Cons EBITDA At Rs 51.8 Cr Vs Rs 45.3 Cr (YoY)
Cons EBITDA Margin At 2.5 percent Vs 2.4 percent (YoY)
NMDC Q4
Net Profit At Rs 511.8 Cr Vs CNBC-TV18 Poll Of Rs 1,020 Cr
Revenue At Rs 2,872 Cr Vs CNBC-TV18 Poll Of Rs 2,750 Cr
Other Income At Rs 134.3 Cr Vs Rs 444.2 Cr (YoY)
Tax Expense At Rs 719 Cr Vs Rs 104 Cr (YoY)
Other stocks and sectors in the news Fortis Healthcare board approves to enhance ceiling limit for FIIs upto 75 percent Renaissance Jewellery to consider buyback at board meeting on May 30 Lypsa Gems board approves bonus issue ITI to issue shares via FPO Max Ventures allots 38 lkh shares upon conversion of warrants VA Tech Wabag wins repeat order from Dangote group for USD 105.5 million UPL subscribed to additional 9 percent shares in Sinagro Group
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!